Table 5. Recommendations.

1	INOCA should be recognized as a clinically important entity in daily clinical practice.
2	A systematic approach to diagnose and treat these patients should be implemented by clinicians and interventional car.diologists dealing with these patients.
3	National and international scientific societies, as well as the pharmaceutical and biomedical industries to support future research to address the incomplete understanding of the pathophysiology, the lack of targeted pharmacological treat.ment, and the evidence-based management of patients with INOCA.
4	Creating awareness of this condition through campaigns and media to ensure timely provision of care to these patients.